1. Home
  2. DRIO

as of 02-10-2026 1:48pm EST

$10.65
+$0.34
+3.30%
Stocks Health Care Medical/Dental Instruments Nasdaq

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Founded: 2011 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 84.1M IPO Year: N/A
Target Price: $50.00 AVG Volume (30 days): 7.8K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -11.36 EPS Growth: N/A
52 Week Low/High: $5.93 - $17.74 Next Earning Date: 03-09-2026
Revenue: $24,732,000 Revenue Growth: 7.29%
Revenue Growth (this year): -9.74% Revenue Growth (next year): 7.64%
P/E Ratio: N/A Index: N/A
Free Cash Flow: -26923000.0 FCF Growth: N/A

AI-Powered DRIO Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 73.38%
73.38%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: